Trevejo Jose M. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Trevejo Jose M.
CHIEF MEDICAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-01+116,424→ 116,424 totalExercise: $20.64Exp: 2032-01-31→ Common Stock (116,424 underlying) - Award
Restricted Stock Units
2022-02-01+30,197→ 30,197 total→ Common Stock (30,197 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.